Suppr超能文献

中药“白芷”(杭白芷)及其近缘野生植物的研究。IV. 中药“白芷”的原植物及栽培历史探讨及其近缘野生植物的演化

[Studies on original plant of traditional Chinese drug "bai zhi" (radix Angelicae Dahuricae) and its closely related wild plants. IV. Discussion on original plant and cultivation history of traditional Chinese drug "bai zhi" and evolution of its closely related wild plants].

作者信息

Wang N H, Huang L Q, Yang B, Baba K, Taniguchi M, Yuan C Q, Qin H Z, Shu P

机构信息

Institute of Botany, Jiangsu Province and Chinese Academy of Sciences, Nanjing 210014, Jiangsu, China.

出版信息

Zhongguo Zhong Yao Za Zhi. 2001 Nov;26(11):733-6.

Abstract

OBJECTIVE

To confirm the original plant of traditional Chinese drug "Bai Zhi" and to inquire into the cultivation history of "Bai Zhi" and evolution of closely related wild plants of "Bai Zhi".

METHOD

Various research results obtained were synthesized and discussed according to historical and current data.

RESULT

Obtained research results, historical and current data showed almost no difference.

CONCLUSION

  1. Angelica dahurica var. formosana must be the original plant of traditional Chinese drug "Bai Zhi". 2. A. porphyrocaulis should be treated as a variety of A. dahurica, named as A. dahurica var. porphyrocaulis. 3. 4 sorts of Chinese traditional drug "Bai Zhi" (Chuang Bai Zhi, Hang Bai Zhi, Qi Bai Zhi and Yu Bai Zhi) should not be taxonomically distinguished. The history of utilization and cultivation of "Bai Zhi", and the evolutional relation of the closely related wild plants of "Bai Zhi" (A. dahurica, A. dahurica var. formosana, and A. dahurica var. porphyrocaulis) were also discussed.
摘要

目的

确定中药“白芷”的原植物,探究“白芷”的栽培历史以及与其近缘野生植物的演化情况。

方法

根据历史和当前数据,综合并讨论所获得的各种研究结果。

结果

所获得的研究结果、历史和当前数据显示几乎没有差异。

结论

  1. 台湾当归必定是中药“白芷”的原植物。2. 紫茎当归应被视为当归的一个变种,命名为当归紫茎变种。3. 4种中药“白芷”(川白芷、杭白芷、祁白芷和禹白芷)在分类学上不应加以区分。还讨论了“白芷”的利用和栽培历史,以及“白芷”近缘野生植物(当归、台湾当归和当归紫茎变种)的演化关系。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验